NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jason Liu: Innovations in NK Cell Targeting for Recurrent Pregnancy Loss
Jason Liu/LinkedIn
Nov 21, 2025, 10:06

Jason Liu: Innovations in NK Cell Targeting for Recurrent Pregnancy Loss

Jason Liu, Managing Editor at Targets MDPI, shared a post on LinkedIn:

“Review paper recommendation

Title: ‘Targeting CD3-CD16+CD56+ NK Cells and NK Cell Activity by Intralipid in the Management of Reproductive Failure’

Full text.

Abstract:
Immunological risk factors in recurrent pregnancy loss include autoantibodies, alterations in NK cell number and function, regulatory T cells, the human leukocyte antigen system (HLA), etc., where the treatment options aim to regulate immune dysfunction. Intralipid is a synthetic product traditionally used as a dietary supplement consisting of soybean oil combined with refined egg phospholipids. It has been shown that intralipid exerts physiologic activities, including altering immunological functions, that may benefit patients with certain types of infertility. In this review, we summarize the current state of the art of targeting NK cells and NK cell activity in women with implantation failure or/and recurrent pregnancy loss. We focus on intralipid mechanisms of action and outcomes of clinical trials regarding the efficacy and safety of intralipid infusions in women with reproductive failure. More studies are needed to reveal all the aspects of the safety and effectiveness of intralipid administration in reproductive failure treatment.”

Stay updated on all scientific advances in the field of fertility with Fertility News.

Assisted Reproductive Technology autoantibodies Clinical Trials Evidence-Based Medicine Fertility Fertility News Health Innovations HLA System Immunological Factors Immunological Functions Implantation Failure Infertility Management infertility treatment Intralipid Jason Liu NK cells Patient Outcomes Recurrent Pregnancy Loss regulatory T cells Reproductive Failure Reproductive Immunology Targets MDPI Treatment Strategies Women’s Health
NewsFeed